Overview
The Department of Health and Human Services revealed Thursday that it plans to build clearer implementation guidance and stronger standards for artificial intelligence in clinical care. GovCIO first reported the announcement. Federal officials say this move responds directly to industry feedback collected earlier this year.
HHS Announces Three Core Priorities
HHS identified three priorities after reviewing responses to its request for information (RFI), which the agency released in December. Over 7,000 industry stakeholders submitted responses, signaling strong interest in AI’s role in healthcare delivery. Additionally, the priorities call for better coordination among federal agencies, including the Advanced Research Projects Agency for Health (ARPA-H).
Why Coordination Matters
Fragmented efforts across agencies often slow down innovation. Therefore, HHS wants ARPA-H, the Defense Health Agency, and related departments to align their strategies. This alignment could reduce duplicated work and speed up AI adoption in clinical settings.
What Sparked the RFI?
HHS launched its RFI to gather direct input from healthcare providers, technology developers, and policy experts. The agency wanted real-world perspectives on the obstacles preventing AI from becoming a standard part of clinical workflows. Consequently, the overwhelming response volume shaped the three priorities HHS just announced.
What Was the Focus of the RFI?
The RFI explored several key questions. First, HHS asked about the biggest barriers blocking AI adoption in clinical care. Next, it sought insight into the innovation challenges that slow progress. The agency also asked whether regulatory or programmatic changes could ease AI integration into everyday clinical practice. Finally, respondents shared their views on which novel AI tools would most effectively improve patient care.
Key Themes From Industry Feedback
Respondents repeatedly flagged regulatory uncertainty and workflow integration as major hurdles. Many also emphasized the need for trust-building measures between providers and AI vendors. These themes directly informed the priorities HHS unveiled this week.
What Did HHS Deputy AI Chief Arman Sharma Say?
HHS Deputy Chief AI Officer Arman Sharma explained that the three priorities form the foundation for building trust between the clinical care community and the government. He pointed to the Agentic AI-Enabled Cardiovascular Care Transformation program, known as ADVOCATE, as ARPA-H’s flagship effort to accelerate AI adoption. However, Sharma acknowledged that strong programs alone cannot close every gap.
The Implementation Gap
Sharma noted that even ideal regulation and optimal reimbursement still leave room for challenges. He said, “There’s still process and workflow optimization that’s required to take AI and bring it into existing workflows within any care setting, whether that be a small clinic or whether that be a large academic medical center.” This statement underscores why HHS now prioritizes implementation guidance over policy alone.
Why This Matters for Healthcare Stakeholders
Clinical AI adoption affects hospitals, payers, and technology vendors alike. As a result, clearer federal guidance could help organizations integrate AI tools more confidently. Moreover, better agency coordination may reduce duplicated efforts and accelerate innovation across the healthcare ecosystem.
Upcoming Industry Discussion
HHS, the Defense Health Agency, and other federal partners will discuss fiscal year 2027 contracting priorities at the Potomac Officers Club’s 2026 Healthcare Summit on December 3. This event offers a valuable opportunity to network and explore new business prospects. Early registration is recommended for those who want to attend.
